Ergoteles’s Genetron Holdings Limited ADS GTH Stock Holding History

Ergoteles’s Portfolio GTH Stock Details GTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-4,232	Closed	-$10K	–	2049
2022 Q3	$10K	Buy	+4,232	New	+$14.2K	﹤0.01%	1481

Other funds holding GTH

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

YRHAM

Yong Rong (HK) Asset Management Sheung Wan, Hong Kong $227M AUM 300.38% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

SSA

Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Ergoteles's GTH Position: Q4 2022 in Review

Ergoteles sold out of Genetron Holdings Limited ADS (GTH) in Q4 2022, closing a stake of 4,232 shares — an estimated $10K sold.

Ergoteles first reported a position in GTH in Q3 2022 and held it in 1 quarter. The position peaked at $10K in Q3 2022. 22 funds tracked by Wall St. Rank hold GTH as of Q4 2022.

Ergoteles reported no remaining Genetron Holdings Limited ADS position as of Q4 2022 after selling out during the quarter.
Ergoteles sold 4,232 Genetron Holdings Limited ADS shares in Q4 2022, an estimated $10K.
Ergoteles first reported a position in Genetron Holdings Limited ADS in Q3 2022 and held it in 1 quarter.
Ergoteles's Genetron Holdings Limited ADS position peaked at $10K in Q3 2022.
22 funds tracked by Wall St. Rank held Genetron Holdings Limited ADS as of Q4 2022.

Based on Ergoteles's 13F filing for Q4 2022, filed 14 Feb 2023.